BNP Paribas’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.8M Buy
103,264
+99,881
+2,952% +$8.9M 0.28% 66
2025
Q4
$369K Sell
3,383
-89,127
-96% -$6.99M 0.01% 220
2025
Q3
$7.5M Buy
92,510
+10,485
+13% +$894K 0.23% 75
2025
Q2
$7.46M Buy
82,025
+11,408
+16% +$1.04M 0.24% 77
2025
Q1
$6.62M Buy
70,617
+70,352
+26,548% +$6.3M 0.27% 78
2024
Q4
$5.84M Hold
265
0.03% 79
2024
Q3
$27.5K Sell
265
-85
-24% -$8.66K ﹤0.01% 289
2024
Q2
$34K Sell
350
-84,751
-100% -$7.82M ﹤0.01% 263
2024
Q1
$7.66M Buy
+85,101
New +$7.21M 0.36% 62

Other funds holding CL

BNP Paribas's CL Position: Q1 2026 in Review

BNP Paribas increased its Colgate-Palmolive (CL) stake by 2,952% in Q1 2026, buying an estimated $8.9M and bringing the position to 103,264 shares worth $8.8M. The position accounts for 0.28% of the portfolio, ranked #66.

BNP Paribas first reported a position in CL in Q1 2024 and has held it in 9 quarters since. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • BNP Paribas held 103,264 shares of Colgate-Palmolive worth $8.8M as of Q1 2026.
  • BNP Paribas bought 99,881 Colgate-Palmolive shares in Q1 2026, an estimated $8.9M.
  • Colgate-Palmolive made up 0.28% of BNP Paribas's portfolio in Q1 2026, its #66 holding.
  • BNP Paribas first reported a position in Colgate-Palmolive in Q1 2024 and has held it in 9 quarters since.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on BNP Paribas's 13F filing for Q1 2026, filed 12 May 2026.